CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BusinessWire Biotech
Original article

Werner® Reports Preliminary Third Quarter 2026 Financial Results

EarningsNeutral
AI Analysis

Summary

Werner Enterprises, a transportation and logistics provider (not a biotech/pharma company), reported preliminary Q3 2026 results with revenue of about $946-$951 million and GAAP diluted EPS of $0.10-$0.11. Non-GAAP adjusted diluted EPS is expected at $0.15-$0.16.

Financial Highlights

Revenue

$946 million to $951 million (preliminary Q3 2026)

EPS

GAAP diluted $0.10-$0.11; non-GAAP adjusted diluted $0.15-$0.16

Outcome Details

Preliminary unaudited Q3 2026 results: total revenues ~$946M-$951M; GAAP diluted EPS ~$0.10-$0.11; non-GAAP adjusted diluted EPS ~$0.15-$0.16

Importance:2/10
Sentiment:
0.00
earningspreliminary resultstransportationlogisticsnon-biotech
Related Companies

Read the original article

Published by BusinessWire Biotech on October 19, 2026 1:00 PM

Read Original